KRH-1636 is an orally available nonpeptide CXCR4 antagonist and, due to the fact that it is absorbed from the duodenum into the bloodstream, can be useful also for the treatment of HIV infection [70]. The gene discussed is CXCR4; the disease is HIV infectious disease.